Evidence map›Paper›PMID 33472926›Full record

ArticleNeurology2021

Incidence, Prevalence, and Health Care Outcomes in Idiopathic Intracranial Hypertension: A Population Study.

Latif Miah, Huw Strafford, Beata Fonferko-Shadrach, Joe Hollinghurst, Inder M S Sawhney, Savvas Hadjikoutis, Mark I Rees, Rob Powell, Arron Lacey, William O Pickrell

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07191873 (A Phase IV Placebo-controlled Single Center Trial for Tirzepatide in Idiopathic Intracranial Hypertension Trial), which is not on this map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07191873 phase4recruitingstarted 2026, after this paper: background citation

A Phase IV Placebo-controlled Single Center Trial for Tirzepatide in Idiopathic Intracranial Hypertension Trial (TIIHT)

Ran2026Enrolled60Registered outcomes4Posted comparisons0ConditionsIdiopathic Intracranial Hypertension (IIH)ArmsTirzepatide, Tirzepatide Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Latif MiahFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.ORCID http://orcid.org/0000-0002-1663-5153
Huw StraffordFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.
Beata Fonferko-ShadrachFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.
Joe HollinghurstFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.
Inder M S SawhneyFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.
Savvas HadjikoutisFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.
Mark I ReesFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.
Rob PowellFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.
Arron LaceyFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia.
William O PickrellFrom Swansea University Medical School (L.M., H.S., B.F.-S., J.H., I.M.S.S., M.I.R., R.P., A.L., W.O.P.), Swansea University; Neurology Department (I.M.S.S., S.H., R.P., W.O.P.), Morriston Hospital, Swansea Bay University Health Board; and Faculty of Medicine and Health (M.I.R.), University of Sydney, Australia. w.o.pickrell@swansea.ac.uk.ORCID http://orcid.org/0000-0003-4396-5657
Swansea Bay University Health Board · GB

Funding

HCRW_ SCF-18-1504
6 · The paper itself

Abstract

objectiveTo characterize trends in incidence, prevalence, and health care outcomes in the idiopathic intracranial hypertension (IIH) population in Wales using routinely collected health care data.

methodsWe used and validated primary and secondary care IIH diagnosis codes within the Secure Anonymised Information Linkage databank to ascertain IIH cases and controls in a retrospective cohort study between 2003 and 2017. We recorded body mass index (BMI), deprivation quintile, CSF diversion surgery, and unscheduled hospital admissions in case and control cohorts.

resultsWe analyzed 35 million patient-years of data. There were 1,765 cases of IIH in 2017 (85% female). The prevalence and incidence of IIH in 2017 was 76/100,000 and 7.8/100,000/y, a significant increase from 2003 (corresponding figures = 12/100,000 and 2.3/100,000/y) (

conclusionsIIH incidence and prevalence is increasing considerably, corresponding to population increases in BMI, and is associated with increased deprivation. This has important implications for health care professionals and policy makers given the comorbidities, complications, and increased health care utilization associated with IIH.

Identifiers

PMID33472926
PMCPMC8055349
OpenAlexW3122772696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.